Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis MENACTRIMS

Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis MENACTRIMS (MENACTRIMS) is a leading non-profit organization dedicated to enhancing research and improving clinical outcomes in multiple sclerosis (MS) across the Middle East and North Africa. Located at Interior Circle / Jordanian News Agency Petra, Amman, Amman 581000, JO, MENACTRIMS serves as a vital hub for clinicians and scientists, fostering collaboration and communication to advance the understanding and treatment of MS.

MENACTRIMS is committed to facilitating synergies among experts in the field, promoting innovative research initiatives, and ensuring the dissemination of best practices in MS care. Through its various programs and activities, MENACTRIMS strives to improve the lives of individuals affected by multiple sclerosis, supporting both patients and healthcare professionals with the latest advancements and resources. MENACTRIMS plays a crucial role in shaping the future of MS treatment and research in the region.

By focusing on collaboration and knowledge-sharing, Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis MENACTRIMS aims to create a positive impact on the MS community, driving progress in patient care and scientific discovery. We invite the management team at Middle East and North Africa Committee for Treatment and Research in Multiple Sclerosis MENACTRIMS to create a customized and exclusive company showcase and product listing on our platform, to further highlight your contributions and connect with a broader audience.